JCO Journals shared a post on LinkedIn:
“We are proud to name Zsofia Stadler, MD as the next Editor-in-Chief of JCO Precision Oncology starting July 1st!
Dr. Stadler is a world-class expert at Memorial Sloan Kettering Cancer Center, specializing in cancer genetics and hereditary predispositions. As the world of cancer care shifts toward AI and genomic technology, Dr. Stadler’s leadership will ensure JCO PO remains the premier destination for research that moves the needle for patients.
“I am honored to lead JCO Precision Oncology as we enter an era where genomics and AI are central to clinical care,”
– said Dr. Stadler.
“My vision is to drive innovation by integrating real-world data and advanced technology to accelerate effective therapies and ensure equitable access to precision medicine for all patients.”
Please join us in welcoming Dr. Stadler!”
Other articles featuring JCO Journals on OncoDaily.